Cargando…

Increasing prevalence of anticholinergic medication use in older people in England over 20 years: cognitive function and ageing study I and II

BACKGROUND: Anticholinergic medication use is linked with increased cognitive decline, dementia, falls and mortality, and their use should be limited in older people. Here we estimate the prevalence of anticholinergic use in England’s older population in 1991 and 2011, and describe changes in use by...

Descripción completa

Detalles Bibliográficos
Autores principales:	Grossi, Carlota M., Richardson, Kathryn, Savva, George M., Fox, Chris, Arthur, Antony, Loke, Yoon K., Steel, Nicholas, Brayne, Carol, Matthews, Fiona E., Robinson, Louise, Myint, Phyo K., Maidment, Ian D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7393714/ https://www.ncbi.nlm.nih.gov/pubmed/32736640 http://dx.doi.org/10.1186/s12877-020-01657-x

Ejemplares similares

Anticholinergic and benzodiazepine medication use and risk of incident dementia: a UK cohort study
por: Grossi, Carlota M., et al.
Publicado: (2019)

Anticholinergic drugs and risk of dementia: case-control study
por: Richardson, Kathryn, et al.
Publicado: (2018)

Anticholinergic drugs and incident dementia, mild cognitive impairment and cognitive decline: a meta-analysis
por: Pieper, Nina T, et al.
Publicado: (2020)

History of Benzodiazepine Prescriptions and Risk of Dementia: Possible Bias Due to Prevalent Users and Covariate Measurement Timing in a Nested Case-Control Study
por: Richardson, Kathryn, et al.
Publicado: (2019)

A novel Artificial Intelligence-based tool to assess anticholinergic burden: a survey
por: Secchi, Agostina, et al.
Publicado: (2022)

Adverse effects of Z-drugs for sleep disturbance in people living with dementia: a population-based cohort study
por: Richardson, Kathryn, et al.
Publicado: (2020)

Anticholinergic burden measures and older people’s falls risk: a systematic prognostic review
por: Stewart, Carrie, et al.
Publicado: (2021)

Higher anticholinergic burden from medications is associated with significant increase in markers of inflammation in the EPIC‐Norfolk prospective population‐based cohort study
por: Sanghavi, Ria, et al.
Publicado: (2022)

Anticholinergic medication exposure predicts poor physical capability: Findings from a large prospective cohort study in England
por: Yrjana, Kaisa R., et al.
Publicado: (2020)

A two-decade comparison of prevalence of dementia in individuals aged 65 years and older from three geographical areas of England: results of the Cognitive Function and Ageing Study I and II
por: Matthews, Fiona E, et al.
Publicado: (2013)

A comparison of health expectancies over two decades in England: results of the Cognitive Function and Ageing Study I and II
por: Jagger, Carol, et al.
Publicado: (2016)

The Prognostic Value of Anticholinergic Burden Measures in Relation to Mortality in Older Individuals: A Systematic Review and Meta-Analysis
por: Graves-Morris, Katherine, et al.
Publicado: (2020)

The cognitive impact of anticholinergics: A clinical review
por: Campbell, Noll, et al.
Publicado: (2009)

The Incidence of Dementia in England and Wales: Findings from the Five Identical Sites of the MRC CFA Study
por: Matthews, Fiona, et al.
Publicado: (2005)

Correction: The Incidence of Dementia in England and Wales: Findings from the Five Identical Sites of the MRC CFA Study
por: Matthews, Fiona, et al.
Publicado: (2005)

Changing prevalence and treatment of depression among older people over two decades
por: Arthur, Antony, et al.
Publicado: (2019)

Potential Value of Impaired Cognition in Stroke Prediction: A U.K. Population‐Based Study
por: Stephan, Blossom C. M., et al.
Publicado: (2017)

Anticholinergic burden in older adult inpatients: patterns from admission to discharge and associations with hospital outcomes
por: Herrero-Zazo, Maria, et al.
Publicado: (2021)

Barriers and facilitators to reducing anticholinergic burden: a qualitative systematic review
por: Stewart, Carrie, et al.
Publicado: (2021)

The oldest old in England and Wales: a descriptive analysis based on the MRC Cognitive Function and Ageing Study
por: Xie, Jing, et al.
Publicado: (2008)

A Predictive In Vitro Model of the Impact of Drugs with Anticholinergic Properties on Human Neuronal and Astrocytic Systems
por: Woehrling, Elizabeth K., et al.
Publicado: (2015)

Occurrence of medical co-morbidity in mild cognitive impairment: implications for generalisation of MCI research
por: Stephan, Blossom C. M., et al.
Publicado: (2011)

Changing non-participation in epidemiological studies of older people: evidence from the Cognitive Function and Ageing Study I and II
por: Gao, Lu, et al.
Publicado: (2015)

A comparison over 2 decades of disability-free life expectancy at age 65 years for those with long-term conditions in England: Analysis of the 2 longitudinal Cognitive Function and Ageing Studies
por: Bennett, Holly Q., et al.
Publicado: (2022)

Anticholinergic burden in middle-aged women and recurrent falls in later life: findings from the Aberdeen prospective osteoporosis screening study (APOSS)
por: Neal, Samuel R., et al.
Publicado: (2020)

Association of Race/Ethnicity and Social Disadvantage With Autism Prevalence in 7 Million School Children in England
por: Roman-Urrestarazu, Andres, et al.
Publicado: (2021)

Is frailty a stable predictor of mortality across time? Evidence from the Cognitive Function and Ageing Studies
por: Mousa, Andria, et al.
Publicado: (2018)

Two-decade change in prevalence of cognitive impairment in the UK
por: Richardson, Connor, et al.
Publicado: (2019)

An investigation of the population impact of variation in HbA(1c )levels in older people in England and Wales: From a population based multi-centre longitudinal study
por: Gao, Lu, et al.
Publicado: (2008)

Understanding Stakeholder Views Regarding the Design of an Intervention Trial to Reduce Anticholinergic Burden: A Qualitative Study
por: Cunningham, Yvonne, et al.
Publicado: (2021)

Behavioural and psychological symptoms in the older population without dementia - relationship with socio-demographics, health and cognition
por: van der Linde, Rianne, et al.
Publicado: (2010)

Does practice analysis agree with the ambulatory care sensitive conditions’ list of avoidable unplanned admissions?: a cross-sectional study in the East of England
por: Fleetcroft, Robert, et al.
Publicado: (2018)

Anticholinergic therapy: A case-based approach
por: Robinson, Dudley, et al.
Publicado: (2019)

Anticholinergic drugs and risk of dementia: Time for action?
por: Bell, Brian, et al.
Publicado: (2021)

Risk Prediction Models for Mortality in Community-Acquired Pneumonia: A Systematic Review
por: Kwok, Chun Shing, et al.
Publicado: (2013)

Cognitive Effects of Anticholinergic Load in Women with Overactive Bladder
por: Araklitis, George, et al.
Publicado: (2020)

Examining the influence of gender, education, social class and birth cohort on MMSE tracking over time: a population-based prospective cohort study
por: Matthews, Fiona, et al.
Publicado: (2012)

Anticholinergic Burden and Most Common Anticholinergic-acting Medicines in Older General Practice Patients
por: Gorup, Eva, et al.
Publicado: (2018)

Can cardiovascular risk management be improved by shared care with general practice to prevent cognitive decline following stroke/TIA? A feasibility randomised controlled trial (SERVED memory)
por: Davison, William J., et al.
Publicado: (2020)

Social activity, cognitive decline and dementia risk: a 20-year prospective cohort study
por: Marioni, Riccardo E., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_vtv972neua9jd1d9b8tq9g8bho